Pure Global
NCT04939571

European Disease Registry on Retinopathy of Prematurity (ROP)

University Medicine Greifswald·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Retinopathy of Prematurity
Drug/Device/Intervention
Registry of preterm born infants with treatment-requiring ROP
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University Medicine Greifswald
Location
Aachen,Berlin,Berlin,Chemnitz,Cologne,Düsseldorf,Freiburg,Greifswald,Göttingen,Hamburg,Lübeck,Münster,Regensburg,Tübingen, Germany
Timeline & enrollment
Phase
N/A
Start date
Aug 06, 2021
End date
Aug 01, 2039
Enrollment
3000 participants
Primary outcome

Baseline data of preterm born infants who develop treatment-requiring retinopathy of prematurity,Treatment parameters at initial treatment,Treatment parameters at re-treatment,ROP stage

Summary

The EU-ROP registry is a European wide multicenter non-interventional observational registry
 study intended to run open-ended in as many countries as possible including infants treated
 for retinopathy of prematurity irrespective of the used treatment modality. The registry is
 strictly observational; only clinical routine data is collected, no study-specific
 examinations or interventions are to be performed.
 
 The aim of the EU-ROP registry is to collect information on as many patients as possible
 treated for ROP in Europe. Both the number of study centers as well as the number of patients
 to be included into the registry are not limited.
 
 The primary objective is to describe the typical clinical features of infants with severe
 ROP, variations in phenotype, and the clinical progression of the disease over time (natural
 history) in different European countries as well as to study treatment patterns, follow-up
 patterns, as well as long-term outcomes.

ICD-10 classifications
Retinopathy of prematurityOther proliferative retinopathyBackground retinopathy and retinal vascular changesDiabetic retinopathyRetinal disorder, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04939571
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04939571 through Pure Global AI's free database. This phase not specified trial is sponsored by University Medicine Greifswald and is currently Recruiting. The study focuses on Retinopathy of Prematurity. Target enrollment is 3000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.